A detailed history of Lazard Asset Management LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 119,251 shares of GH stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119,251
Previous 136,269 12.49%
Holding current value
$3.89 Million
Previous $3.94 Million 30.52%
% of portfolio
0.0%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $379,501 - $617,583
-17,018 Reduced 12.49%
119,251 $2.73 Million
Q2 2024

Aug 14, 2024

SELL
$16.07 - $31.84 $24,072 - $47,696
-1,498 Reduced 1.09%
136,269 $3.94 Million
Q1 2024

May 14, 2024

SELL
$17.13 - $26.91 $211,898 - $332,876
-12,370 Reduced 8.24%
137,767 $2.84 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $132,803 - $181,543
-6,154 Reduced 3.94%
150,137 $4.06 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $1.04 Million - $1.61 Million
-40,330 Reduced 20.51%
156,291 $4.63 Million
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $4,125 - $7,487
-197 Reduced 0.1%
196,621 $7.04 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $979,852 - $1.44 Million
42,751 Added 27.75%
196,818 $4.61 Million
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $1.63 Million - $3.84 Million
-64,244 Reduced 29.43%
154,067 $4.19 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $357,269 - $499,163
8,183 Added 3.89%
218,311 $11.8 Million
Q2 2022

Aug 09, 2022

BUY
$28.82 - $77.35 $2.88 Million - $7.73 Million
99,893 Added 90.62%
210,128 $8.48 Million
Q1 2022

May 13, 2022

BUY
$48.25 - $100.49 $1.26 Million - $2.63 Million
26,217 Added 31.2%
110,235 $7.3 Million
Q4 2021

Feb 09, 2022

BUY
$88.71 - $120.43 $3.82 Million - $5.18 Million
43,054 Added 105.1%
84,018 $8.4 Million
Q3 2021

Nov 15, 2021

BUY
$98.77 - $132.17 $763,393 - $1.02 Million
7,729 Added 23.26%
40,964 $5.12 Million
Q2 2021

Aug 12, 2021

BUY
$109.77 - $165.68 $3.59 Million - $5.42 Million
32,717 Added 6316.02%
33,235 $4.13 Million
Q1 2021

May 14, 2021

SELL
$127.04 - $179.1 $8,638 - $12,178
-68 Reduced 11.6%
518 $79,000
Q4 2020

Feb 11, 2021

BUY
$99.96 - $135.93 $58,576 - $79,654
586 New
586 $75,000
Q3 2020

Nov 13, 2020

SELL
$80.32 - $111.8 $3,775 - $5,254
-47 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$60.49 - $97.5 $2,843 - $4,582
47 New
47 $3,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.